Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension

Figures

• 

  Figure 1. Mean TTO utility scores for each PAH health state. Notes: *p-value vs oral health state; p<0.001; mixed model F = 92.4, p<0.001. Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; TTO, time trade-off.

• 

  Figure 2. Mean VAS utility scores for each PAH health state. Notes: *p-value vs oral health state; p<0.001; mixed model F = 326.5, p<0.001. Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; VAS, visual analog scale.

• 

  Figure 3. Mean disutilities of TTO utility scores for each non-oral vs oral PAH health state. Notes: *p-value vs oral health state; p<0.001. Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; TTO, time trade-off.